Management of Chronic Post-Partum Pelvic Girdle Pain Study
Launched by UNIVERSITY OF PLYMOUTH · Jan 6, 2016
Trial Information
Current as of June 26, 2025
Completed
Keywords
ClinConnect Summary
Pelvic girdle pain (PGP) occurs in 70% of pregnant women; of whom 25% have severe pain and 8% severe disability requiring the use of crutches, wheelchair or confinement to bed (Wu et al, 2004). At a personal level, women with PGP find that everyday activities such as turning in bed, prolonged walking, or carrying items may cause pain; impacting negatively on quality of life (Wang et al, 2004). In economic terms societal costs are significant, mainly as a consequence of work absenteeism; with 20% of people requiring an average of 7 weeks sick leave (Noren et al, 1997). The impact of this pro...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria: Women with PGP (commenced or aggravated during pregnancy) will be included if they:
- • have symptoms that continued for \> 3 months following birth,
- • have PGP that causes walking and/or stair climbing to be bothersome (as determined by a score of at least 2 on a 10 point visual analogue scale)
- • are positive on at least 3 out of 7 pain provocation tests (see screening section below)
- Exclusion Criteria: Women will be excluded if they have:
- • A recent history/signs or symptoms indicative of serious causes of pain that might be inflammatory infective, traumatic, neoplastic, degenerative or metabolic.
- In particular exclusion will occur if following questioning or clinical examination there is evidence of:
- • trauma
- • Indicators of serious pathology
- • steroid use
- • drug abuse
- • HIV infection
- • immunosuppressed state
- • neurological symptoms/signs (including cauda-equina)
- • fever
- • systemically unwell
- • obstetric complications
- • pain that does not improve with rest/severe disabling pain
- • history of chronic back or pelvic pain requiring surgery.
- • a known skin allergy to Lycra
About University Of Plymouth
The University of Plymouth is a renowned academic institution dedicated to advancing research and innovation in various fields, including health and clinical sciences. As a clinical trial sponsor, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous research aimed at improving patient outcomes and informing healthcare practices. With a commitment to ethical standards and collaboration, the University of Plymouth fosters partnerships with healthcare providers, industry stakeholders, and regulatory bodies to ensure the successful design, implementation, and dissemination of clinical trials that contribute to the body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bristol, Avon, United Kingdom
Plymouth, Devon, United Kingdom
Patients applied
Trial Officials
Lee Cameron
Principal Investigator
University of Plymouth
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials